New DSRCT registry aims to unlock secrets of rare cancer
NCT ID NCT04690374
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a patient registry for people diagnosed with desmoplastic small round cell tumor (DSRCT), a rare cancer. Researchers will collect health information from up to 250 participants of any age to build a database for current and future studies. The goal is to better understand DSRCT, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESMOPLASTIC SMALL ROUND CELL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITINGNew York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive antibody targets rare childhood cancer
- New immunotherapy targets genetic flaw in rare childhood cancers
- New hope for tough tumors: Half-Matched bone marrow transplant trial
- New drug cocktail aims to keep childhood cancers at bay
- New drug cocktail aims to tackle tough sarcomas in young patients
- New cocktail of four drugs aims to tackle childhood cancers that Won't go away